GelSight and Meta AI Introduce Digit 360 Tactile Sensor
Digit 360 deepens GelSight and Meta AI’s existing partnership and fosters a community-driven approach to robotics research
South 8’s LiGas® Liquefied Gas Electrolyte Named to TIME’s List of the Best Inventions of 2024
Recognition as one of 200 world-changing innovations validates how LiGas can improve the performance, safety, and cost of lithium-ion batteries
Liquid Instruments Integrates AI with Reconfigurable Test Instrumentation, Opening New Ways to Connect Machine Learning to the Physical World
Neural Network instrument enables users to develop, train, and deploy custom AI models for real-time signal processing and experimental applications
Anzu Partners Welcomes Joey Clark as Principal and Senior Vice President of Capital Solutions
Boston BioProducts adopts Nirrin’s Atlas system to enhance Quality Control (QC) testing and set new quality standards
Nirrin Technologies and Boston BioProducts Raise the Bar on Quality Excellence in GMP Buffer Manufacturing
Boston BioProducts adopts Nirrin’s Atlas system to enhance Quality Control (QC) testing and set new quality standards
RTI International and Codetta Bio™ announce strategic collaboration to accelerate healthcare innovation
Collaboration follows RTI’s equity investment in Codetta Bio
Niron Magnetics Opens the World’s First Manufacturing Facility for Powerful Rare-Earth-Free Permanent Magnets
Next-generation technology will help engineering students acquire hands-on skills to succeed in the modern workforce
VTU Transforms Engineering Education in Karnataka with Reconfigurable Instrumentation from Liquid Instruments
Next-generation technology will help engineering students acquire hands-on skills to succeed in the modern workforce
AM Batteries Ships First Rolls of Electrodes to Make EVs More Affordable
Leading US battery equipment manufacturer hits major milestone in scaling dry battery electrode technology for commercialization; works with major battery cell supplier for validation
BioSkryb Genomics Partners with the Human Cell Atlas to Advance Access to the Next Generation of Single-Cell Technology
New partnership will increase access to BioSkryb’s industry-leading single-cell multiomics technology